Global E. Coli Testing Market 2016-2020

  • ID: 3623650
  • Report
  • Region: Global
  • 49 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Accugen Laboratories
  • Becton
  • Bio-Rad Laboratories
  • EIKEN CHEMICAL
  • InstantLabs
  • Meridian Bioscience
  • MORE
About E. coli Testing

Escherichia coli (E. coli) are the leading cause of diarrheal diseases worldwide, especially among children. E. coli infection primarily occurs through food or drinking water contaminated with animal or human feces. The bacteria produce Shiga toxin that causes gastrointestinal (GI) infections with symptoms including bloody diarrhea and vomiting. Though the infections are usually cured in a few days, at times, they may lead to hemolytic uremic syndrome. This syndrome, if untreated, can result in kidney failure. E. coli tests are used to diagnose GI infections using stool samples. These tests can be performed using molecular diagnostic kits and immunoassays.

The analysts forecast the global E. coli testing market to grow at a CAGR of 5.81% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global E. coli testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the following segments in E. coli testing market:

- Consumables: Assays, reagents, and kits
- Instruments: Laboratory benchtop devices

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global E. coli Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors:

- Alere
- Becton, Dickinson and Company (BD)
- bioMérieux
- Meridian Bioscience

Other prominent vendors:

- Accugen Laboratories
- Bio-Rad Laboratories
- Diasorin
- EIKEN CHEMICAL
- Enzo Life Sciences
- InstantLabs
- Luminex Corporation
- Mobidiag
- Nanosphere
- Pro-Lab Diagnostics
- QIAGEN
- Romer Labs
- Vivione Biosciences

Market drivers

- Increasing incidences of diarrhea
- For a full, detailed list, view the full report

Market challenges

- Limitations of PCR-based pathogen detection
- For a full, detailed list, view the full report

Market trends

- Increasing adoption of multiplex PCR technology
- For a full, detailed list, view the full report

Key questions answered in this report

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Accugen Laboratories
  • Becton
  • Bio-Rad Laboratories
  • EIKEN CHEMICAL
  • InstantLabs
  • Meridian Bioscience
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Reimbursement and coverage: An overview

PART 07: Market segmentation by product

PART 08: Technology platforms for E. coli testing
  • Molecular diagnostics
  • Immunoassay
  • Other
PART 09: Geographical segmentation
  • Global E. coli testing market by geography 2015-2020
  • E. coli testing market in Americas
  • E. coli testing market in EMEA
  • E. coli testing market in APAC
PART 10: Market drivers
  • Increasing incidences of diarrhea
  • Growing demand for accurate diagnostic technology
  • Increase in drug-resistant E. coli strains
  • Government initiatives to improve healthcare services
PART 11: Impact of drivers

PART 12: Market challenges
  • Limitations of PCR-based pathogen detection
  • Lack of skilled workforce
  • Stringent regulatory environment
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Increasing adoption of multiplex PCR technology
  • Use of isothermal nucleic acid amplification method
  • Increase in strategic alliance by vendors
PART 15: Vendor landscape
  • Competitive scenario
  • Market share analysis 2014
  • Alere
  • BD
  • bioMérieux
  • Meridian Bioscience
  • Other prominent vendors
PART 16: Appendix
  • List of abbreviations
PART 17: About Author

List of Exhibits

Exhibit 01: Product offerings 7
Exhibit 02: Global E. coli testing market 2015-2020 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Reimbursement perspectives of healthcare entities
Exhibit 05: Global E. coli testing market by product 2020
Exhibit 06: Global E. coli testing market by product 2015-2020
Exhibit 07: Global E. coli testing market by consumables 2015-2020 ($ millions)
Exhibit 08: Global E. coli testing market by instruments 2015-2020 ($ millions)
Exhibit 09: Global E. coli testing market by technology
Exhibit 10: Global E. coli testing market by geography 2015
Exhibit 11: Global E. coli testing market by geography 2020
Exhibit 12: Global E. coli testing market by geography 2015-2020
Exhibit 13: E. coli testing market in Americas 2015-2020 ($ millions)
Exhibit 14: E. coli testing market in EMEA 2015-2020 ($ millions)
Exhibit 15: E. coli testing market in APAC 2015-2020 ($ millions)
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Alere: Key takeaways
Exhibit 19: Alere: Business segmentation by revenue 2014
Exhibit 20: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 21: Alere: Geographical segmentation by revenue 2014
Exhibit 22: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 23: BD: Key takeaways
Exhibit 24: bioMérieux: Key takeaways
Exhibit 25: Meridian Bioscience: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Accugen Laboratories
  • Becton
  • Bio-Rad Laboratories
  • EIKEN CHEMICAL
  • InstantLabs
  • Meridian Bioscience
  • MORE
New Report Released: – Global E. coli Testing Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global E. coli Testing Market: Alere, Becton, Dickinson and Company (BD), bioMérieux and Meridian Bioscience.

Other Prominent Vendors in the market are: Accugen Laboratories, Bio-Rad Laboratories, Diasorin, EIKEN CHEMICAL, Enzo Life Sciences, InstantLabs, Luminex Corporation, Mobidiag, Nanosphere, Pro-Lab Diagnostics, QIAGEN, Romer Labs and Vivione Biosciences.

Commenting on the report, an analyst from the research team said: “Increasing adoption of multiplex PCR technology is the current trend in the market. Multiplexing is a method used to detect two or more analytes simultaneously in a single sample. This method is currently integrated with different IVD methods, including immunoassay-, clinical chemistry-, and nucleic acid-based diagnostics. Multiplexing increases the accuracy by limiting the variations during the testing, also many samples can be analyzed at the same time. It reduces the cost and time consumed for specific diagnosis of infectious agents.”

According to the report, increasing incidence of diarrhea and high demand for accurate diagnostic technology are the major factors that drive the growth of the global E. coli testing market. It is estimated that around two billion cases of diarrheal diseases occur every year. Various pathogenic bacteria such as E. coli and Clostridium difficile are responsible for causing diarrhea. The need to diagnose the exact cause of diarrhea accurately for effective treatment propels the demand for E. coli testing products and drive market growth.

Further, the report states that Currently, PCR is a popular method of testing for the diagnosis of different diseases in a clinical setting. However, it has certain limitations. This method is not useful in predicting the viability of the pathogen linked to the disease, and, therefore, could yield a false positive outcome.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Alere
- Becton
- Dickinson and Company (BD)
- bioMérieux
- Meridian Bioscience
- Accugen Laboratories
- Bio-Rad Laboratories
- Diasorin
- EIKEN CHEMICAL
- Enzo Life Sciences
- InstantLabs
- Luminex Corporation
- Mobidiag
- Nanosphere
- Pro-Lab Diagnostics
- QIAGEN
- Rome
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll